Elsevier

Pharmapendium Efficacy Module FAQ Sheet

Last updated on September 30, 2023

The Pharmapendium Efficacy Module FAQ Sheetopens in new tab/window provides information about the following:

  • Which reference standard is used to classify the indications categories?
  • How was the endpoint taxonomy developed?
  • What sources are used for efficacy data extraction?
  • How often is the content updated?
  • How do I get the associated activity, pharmacokinetic, metabolizing enzymes and transporters, and/or drug safety data for drugs which are retrieved from my Efficacy Search?
  • Can I export the data?
  • I have found that some drugs have no data for Phase I or Phase II trials.
    Why is that?
  • Why is the interface for the Efficacy Module different than
    the other data modules?
  • What are the years associated with the Age Groups?
  • How do I interpret a combined age group such as “Adult-Aged”?
  • Why is it that the numbers do not match when I select Placebo
    (under the “Placebo/Non-Placebo” Filter) and under the comparative group?
  • When I start a search with Indications, why do I not see any preclinical data?

You can view the document hereopens in new tab/window.

Did we answer your question?

Related answers

Recently viewed answers

Functionality disabled due to your cookie preferences

For further assistance: